Health
AstraZeneca Oxford vaccine’s human trial to begin again
The trial of the covid-19’s AstraZeneca Oxford vaccine was cancelled after a volunteer in Britain became ill. Now the trial is going to start again . Dr. Dheeraj Kaul from New York said on call that Volunteer in the UK had to stop the trial of the AstraZeneca Oxford vaccine due to a problem with […]
Covid-19: America is now bringing Corona vaccine after Russia
New Delhi: According to the latest development from USA, USA is ready for vaccine of Covid-19 in all its states in early October. Just a few weeks ago, Russia announced the Covid-19 vaccine. According to US-based sources, the three major companies in the US are ‘Moderna’, ‘BioNTech and Pfizer’ and ‘AstraZeneca Oxford’. Covid — 19 […]
India at the forefront in repurposing Drugs during COVID-19 to maintain supply chain across world: Expert Says
In the wake of COVID-19, Pharma marketing is embracing digitisation. India’s share in world’s Vaccine production is 50%, making it the largest supplier 21st August 2020: Hardly any industry has left unaffected due to the unprecedented scourge of COVID-19. And the pharma industry is no exception to this. What sort of challenges Pharma industry has […]
Delaying treatment due to the pandemic can worsen the outcome
Mumbai: A 60-year-old man Mr. Pankaj Shah (Name changed) from Chembur ignored his diabetes and ended up with uncontrolled diabetes and lower left leg gangrene. The patient underwent multiple debridements with the cleaning of wound with continuous irrigation negative pressure therapy (a special type of dressing) And his leg was saved at Zen Multispeciality Hospital, […]
COVID-19 to Stay in India: Life to Continue in New Normal
Changing dynamics in healthcare sees new adaptations such as change in Doctor-Patient relationship and availability of time for doctors to rediscover themselves The unfolding situations of COVID-19 in India exemplify that it is here to stay. No one expected that the pandemic will change the dynamics of healthcare, setting a new normal. As the pandemic […]
Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. 35 per tablet
Mumbai, August 04, 2020: Sun Pharmaceutical Industries Limited. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that it has launched FluGuard® (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the treatment of mild to moderate cases of Covid-19 […]
